Clincosm LogoSign in Get a demo

squamous cell carcinoma of the head and neck

Showing 26 - 50 of 150
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in New

Completed
Has Results
  • Head and Neck Cancer
  • +2 more
  • ADXS11-001 (ADXS-HPV)
  • New York, New York
  • +1 more
Sep 9, 2022

ResiduAl Cancer With Liquid Biopsy Evaluation

Recruiting
  • Bladder Carcinoma
  • +14 more
  • Guardant Reveal
  • Redwood City, California
    Redwood City
Sep 7, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (Xevinapant (Debio 1143), Cisplatin, Intensity Modulation

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Xevinapant (Debio 1143)
  • +3 more
  • Gilbert, Arizona
  • +280 more
Aug 22, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla, San Francisco, Torrance (Pembrolizumab)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • La Jolla, California
  • +2 more
Aug 17, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Le Havre (Pembrolizumab, Cetuximab, Radiotherapy)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Le Havre, France
    Centre Guillaume le conquérant
Aug 18, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Duarte, Portland (Atezolizumab, Tiragolumab, Immune-modulating

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Duarte, California
  • +1 more
Aug 16, 2022

NSCLC, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma Trial in San Antonio, West Valley City,

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
  • San Antonio, Texas
  • +2 more
Aug 15, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Decisional Conflicts, Health-related QoL and Satisfaction With

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +9 more
  • Regular care with additionally administration of questionnaires
  • Nijmegen, Gelderland, Netherlands
  • +1 more
Jul 28, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Nivolumab+Relatlimab, Nivolumab+Ipilimumab)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 13, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Cleveland (Pembrolizumab, IMRT 60-66Gy)

Completed
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • Cleveland, Ohio
  • +1 more
Jun 29, 2022

NSCLC, Squamous Cell Carcinoma of the Head and Neck, Ovarian Cancer Trial in United States (PF-07257876)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • PF-07257876
  • Phoenix, Arizona
  • +38 more
Jun 28, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in United Kingdom (NG-641, Pembrolizumab)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • NG-641
  • Pembrolizumab
  • Cardiff, United Kingdom
  • +3 more
Jun 23, 2022

Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma, Head and Neck Trial in Saint Louis (Mitomycin-C,

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Squamous Cell Carcinoma, Head and Neck
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 21, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in France, Switzerland (Cisplatin, Radiotherapy, Debio 1143)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Lorient, Bp 2233, France
  • +18 more
Jun 22, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Little Rock (Robust Radiotherapy planning, Margin-Based Radiotherapy

Enrolling by invitation
  • Squamous Cell Carcinoma of the Head and Neck
  • Robust Radiotherapy planning
  • Margin-Based Radiotherapy planning
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Jun 8, 2022

Human Papilloma Virus, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Chicago (Carboplatin,

Recruiting
  • Human Papilloma Virus
  • +4 more
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 3, 2022

Nivolumab in Squamous Cell Carcinoma of Head & Neck - Patient

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Nivolumab
  • Mount Laurel, New Jersey
    Local Institution
May 2, 2022

Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in Atlanta, Chicago, Philadelphia (Pembrolizumab, Placebo)

Active, not recruiting
  • Head and Neck Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Atlanta, Georgia
  • +3 more
Apr 13, 2022

PET-imaging in Squamous Cell Carcinoma Located in Head and Neck

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Intensity Modulated Proton Therapy (IMPT) +/- Chemotherapy
  • Delft, Zuid-Holland, Netherlands
    Holland Proton Therapy Centre (HollandPTC)
Apr 1, 2022

Squamous Cell Carcinoma of the Head and Neck, Oral Cancer, Squamous Cell Carcinoma of the Oral Cavity Trial in Rotterdam

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • +2 more
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus University Medical Center
Mar 23, 2022

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Granada, Andalucia, Spain
  • +19 more
Mar 22, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Tampa (Cisplatin, Stereotactic Body Radiation Therapy (SBRT))

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Cisplatin
  • Stereotactic Body Radiation Therapy (SBRT)
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022

Cancer, Solid Tumor, Melanoma Trial in United States (ST-067)

Recruiting
  • Cancer
  • +7 more
  • ST-067
  • Scottsdale, Arizona
  • +3 more
Mar 21, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in France (Durvalumab with Carboplatin/Paclitaxel)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Durvalumab with Carboplatin/Paclitaxel
  • Amiens, France
  • +19 more
Mar 14, 2022